Bristol-Myers Squibb to acquire Mirati in $5.8 billion deal

France Nouvelles Nouvelles

Bristol-Myers Squibb to acquire Mirati in $5.8 billion deal
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 97%

Bristol-Myers Squibb (BMY.N) on Sunday said it will acquire Mirati Therapeutics (MRTX.O) in a transaction that values the cancer drugmaker at up to $5.8 billion.

Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File PhotoMirati stockholders will receive one non-tradeable contingent value right for each Mirati share held, potentially worth $12.00 per share in cash, representing an additional $1 billion of value opportunity, the company added.

The transaction will help grow Bristol-Myers’s oncology franchise with the addition of Mirati's lung cancer drug Krazati. Bristol is buying Mirati at a time when the shares are considerably cheaper than they were. Mirati's shares touched a 52-week high of $101.3 apiece on Nov. 28 and are now trading at $60.2.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Bristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Lire la suite »

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionBristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionDeal expands pharmaceutical company’s portfolio of cancer drugs
Lire la suite »

Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionBristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionMirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its...
Lire la suite »

Elyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulElyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulFrom adult diapers to a mini-fridge, Elyse Myers reveals the products she can't live without since giving birth to her second child.
Lire la suite »

Lucrative Bristol Bay red king crab fishery to reopen after 2-year closureLucrative Bristol Bay red king crab fishery to reopen after 2-year closureThe Alaska Department of Fish and Game announced Friday morning that the lucrative crab fishery will open Oct. 15.
Lire la suite »

Something went wrong. Please disable your blocker on Collider.Something went wrong. Please disable your blocker on Collider.Michael Myers and Pinhead could have teamed up to raise hell together!
Lire la suite »



Render Time: 2025-03-01 11:41:50